The leaves of the henna plant contain a potent oxidant, lawsone (2-hydroxy-1, 4-naphthoquinone), that was recently reported to cause acute hemolytic anemia and hyperbilirubinemia in a 4-day old infant (50)
Treatment should be continued only if there has been a beneficial metabolic response, typically defined as a reduction in HbA1c of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight
Whether you are considering Ozempic, Wegovy, or a compounded alternative, being prepared for side effects makes the transition much smoother
NICE guidance supports the use of Rybelsus in specific clinical scenarios where glycaemic targets are not met with first-line therapies
Extended peptide stability through bacteriostatic diluent for injection reduces wastage
Second Nature offers comprehensive lifestyle support to maximise medication effectiveness at the lowest effective dose